Monovalent oral poliovirus vaccines - A good tool but not a total solution

New England Journal of Medicine

Volumn 359, Issue 16, 2008, Pages 1726-1727

  Ehrenfeld, Ellie ^a   Chumakov, Konstantin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE; TRIPLE VACCINE;

DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EDITORIAL; IMMUNOGENICITY; INFECTION PREVENTION; MASS IMMUNIZATION; NIGERIA; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINE FAILURE; VIRUS EXCRETION; VIRUS TRANSMISSION;

EID: 54049087818     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0806810     Document Type: Editorial

References (8)

1. Cáceres VM, Sutter RW. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis 2001;33:531-41.
2. Jenkins HE, Aylward RB, Gasasira A, et al. Effectiveness of immunization against paralytic poliomyelitis in Nigeria. N Engl J Med 2008;359:1666-74.
3. El-Sayed N, El-Gamal Y, Abbassy A-A, et al. Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med 2008;359:1655-65.
4. Grassly NC, Wenger J, Durrani S, et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study. Lancet 2007;369:1356-62. [Erratum, Lancet 2007;369:1790.]
5. Dowdle WR, De Gourville E, Kew OM, Pallansch MA, Wood DJ. Polio eradication: the OPV paradox. Rev Med Virol 2003;13:277-91.
6. Ehrenfeld E, Glass RI, Agol VI, et al. Immunisation against poliomyelitis: moving forward. Lancet 2008;371:1385-7.
7. Chumakov K, Ehrenfeld E, Wimmer E, Agol VI. Vaccination against polio should not be stopped. Nat Rev Microbiol 2007;5:952-8.
8. The Cuba IPV Study Collaborative Group. Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. N Engl J Med 2007;356:1536-44.